ASIA unversity:Item 310904400/112926
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 90452/105769 (86%)
造访人次 : 11946684      在线人数 : 395
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    ASIA unversity > 醫學暨健康學院 > 心理學系 > 期刊論文 >  Item 310904400/112926


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/112926


    题名: The Role of N-methyl-D-aspartate Receptor on Late-Life Depression
    作者: Hsi, Men-Ting;Hsieh, Men-Ting;藍先元;Lane, Hsien Yuan;Chieh-Hsin, L;Lin, Chieh-Hsin
    贡献者: 心理學系
    关键词: N-methyl-D-aspartate receptor ; NMDA ; NMDAR ; late-life depression
    日期: 2019-12
    上传时间: 2020-09-03 16:02:37 (UTC+8)
    出版者: 亞洲大學
    摘要: As the life expectancy of general population becomes longer, the prevalence of geriatric mental disorders increases rapidly. Late-life depression (LLD) is the secondly common mental disorders in the elders. LLD has negative impacts on patient's life and is also related to multiple physical diseases, mental problems, and dementia. Treating LLD is important, but there is a substantial proportion of patients with depression who do not show satisfactory therapeutic response or recovery with current antidepressant treatment. Thus, developing new medication is important. Recent studies showed that abnormal activation of N-methyl-D-aspartate receptor (NMDAR) would result in several neurological and psychiatric disorders, such as major depressive disorder, schizophrenia, Alzheimer's disease, and Parkinson diseases. Medication associated with NMDAR is considered to have great potential in treating depression. NMDAR could be activated by glutamate and in turn initiating signaling cascades which are involved in both neural connectivity and neural plasticity. Also, several animal studies suggest that aging alters the expression of NMDAR. The binding functions and intensities of NMDARs decline in aging animal models. Thus, medication involving with NMDARs might take important role in treating depression, especially in the elders. Current medication related with NMDARs includes nonselective NMDAR antagonists (such as ketamine), selective NMDAR antagonists, NMDA agonist and partial agonists, and glutamate release inhibitors. However, more clinical studies should be conducted to investigate the antidepressant effects of these medications.
    關聯: International Journal of Gerontology
    显示于类别:[心理學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML9检视/开启


    在ASIAIR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈